https://www.linkedin.com/posts/bavariannordic_bavariannordic-mpox-communities-activity-7406633872639016960-Rm5l?

Skal Californien og andre stater have deres egen sundhedsmyndighed?

I kølvandet på kritik af amerikanske føderale sundhedsmyndigheder som CDC, især omkring håndtering af vaccinationer og offentlig kommunikation om sygdomsforebyggelse, har flere amerikanske delstater - med Californien i spidsen - taget initiativ til at skabe et regionalt sundhedssamarbejde. Dette samarbejde er formelt kendt som West Coast Health Alliance og omfatter bl.a. Californien, Oregon, Washington og Hawaii. Det sigter mod at koordinere evidensbaserede anbefalinger om vacciner, sygdomsforebyggelse og andre offentlige sundhedsindsatser uden nødvendigvis at være afhængig af CDC's udmeldinger.

Nylige informationer:

Newsom appoints ex-CDC officials to lead California’s new public health network

Dr Susan Monarez to head PHNIX, a response to Trump administration’s dismantling of public health safeguards

the Guardian (www.theguardian.com)

California hires ex-CDC leaders who were fired or quit under Trump

California is hiring former senior Centers for Disease Control and Prevention officials to help launch a public health initiative in response to the Trump administration's changes to health guidance.

AP News (apnews.com)

Many States Say They’ll Defy RFK Jr.’s Changes to Hepatitis B Vaccination

Most Democratic-led states will continue to recommend the hepatitis B vaccine at birth, despite a CDC advisory panel’s vote against it.

WIRED (www.wired.com)

https://www.cdph.ca.gov/i-am-looking-for/what’s-new/public-health-for-all

Jeg har posted lidt om dette tilbage i efteråret:

California, Oregon, Washington, Hawaii form health alliance in response to CDC changes on vaccine guidance

California, Oregon, Washington and Hawaii announced the formation of a health alliance to guide residents on vaccines and immunizations because of what a joint statement called "the politicization of science" by the federal government.

(www.cbsnews.com)

California, West Coast states roll out their own vaccine guidance amid clash with CDC

California breaks from CDC with new vaccine guidance, and lawmakers propose $23-billion science funding plan.

Los Angeles Times (www.latimes.com)

West Coast Health Alliance - Wikipedia

(en.wikipedia.org)

West Coast states launch new alliance to uphold science in public health

In response to federal actions that have undermined the independence of the CDC and raised concerns about the politicization of science, California, Oregon, and Washington have launched a new West Co...

CMADocs (www.cmadocs.org)

Bavarian Nordic

15/12 Bavarian Nordic "Dialogue matters."

https://www.linkedin.com/posts/bavariannordic_bavariannordic-growth-shareholders-activity-7406244925723545600-Hs-a/

15/12 Unicef - "Donation fra Bavarian Nordic" 20.000 mpox vaccines

Jeg er holdt op med at forsøge at holde styr på alle de donationer fra Bavarian Nordic... Man skulle tro, at BN havde lyst til at offentliggøre donationerne og få lidt goodwill....

Yesterday, Liberia received 20,000 doses of the MVA-BN mpox vaccine, out of part of a 32,000-dose donation from Bavarian Nordic to help protect children and communities at greater risk of… | UNICEF Supply

Yesterday, Liberia received 20,000 doses of the MVA-BN mpox vaccine, out of part of a 32,000-dose donation from Bavarian Nordic to help protect children and communities at greater risk of mpox. Liberia is among the countries reporting the highest number of mpox cases: over the past six weeks, 332 cases and two deaths have been recorded.    Since mpox was declared a public health emergency in August 2024, UNICEF and partners have delivered around 5 million doses of mpox vaccine across Africa to help curb outbreaks. This includes the delivery of 1.9 million doses of MVA-BN vaccine, in collaboration with Gavi, the Vaccine Alliance, World Health Organization, and Africa CDC.    UNICEF thanks Bavarian Nordic for the donated MVA-BN mpox vaccine doses, which will help strengthen national responses and protect lives. UNICEF looks forward to continued collaboration to help protect children from this deadly disease.

LinkedIn (www.linkedin.com)

15/12 "The UK's new approach to Africa" - Statement

"It is consistent with the principles of our modernised approach to international development, recognising we are not just donors. We are partners, investors, and reformers."

"Responding to the consultation, the UK's new approach provides a high-level framing to guide the government's long-term engagement with African partners, reaffirming the shift from paternalism to a partnership of respect and equality. "

Just a moment...

(questions-statements.parliament.uk)

16/12 - GAVI - mRNA vaccines - 4 year study - 30 million adults

"Massive four-year study finds no increase in deaths linked to COVID-19 mRNA vaccination" + "Data from 30 million French adults suggests COVID-19 vaccines did not lead to higher death rates. Instead, they reduced them."

Gavi, the Vaccine Alliance

For years, vaccine sceptics claimed mRNA vaccines would cause delayed harms like increased deaths from cancer, heart disease or other causes. A massive...

(www.facebook.com)

Massive four-year study finds no increase in deaths linked to COVID-19 mRNA vaccination

Data from 30 million French adults suggests COVID-19 vaccines did not lead to higher death rates. Instead, they reduced them.

(www.gavi.org)

Mpox

15/12 Nature "Development of a replication-defective mpox virus platform for fundamental and therapeutic research"

https://www.nature.com/articles/s41467-025-67487-w

11/12 "Mpox downgrade likely as more countries reach 'end phase - Africa CDC - Vanguard News"

Just a moment...

(www.vanguardngr.com)

11/12 AI Finds New Target for Next-Gen Mpox Vaccines ' Technology Networks

ERROR: The request could not be satisfied

(www.technologynetworks.com)

Chikungunya

15/12 Gavi "The pain after the bite: Tracking Chikungunya's debilitating impact in East Africa"

Cases of a mosquito-borne virus that causes crippling disabilities are surging worldwide. Experts are working out how many people are affected in Kenya and Tanzania.

The pain after the bite: Tracking Chikungunya’s debilitating impact in East Africa

Cases of a mosquito-borne virus that causes crippling disabilities are surging worldwide. Experts are working out how many people are affected in Kenya and Tanzania.

(www.gavi.org)

15/12 CEPI - Zika - "diagnostic testing later showed that these infections were caused by the Chikungunya virus. "

While the world battled Zika in the Summer of 2016, Kenya quietly faced its own mosquito-driven crisis. In the coastal county of Kilifi, newborns were being hospitalised with what looked to be… | CEPI (Coalition for Epidemic Preparedness Innovations)

While the world battled Zika in the Summer of 2016, Kenya quietly faced its own mosquito-driven crisis. In the coastal county of Kilifi, newborns were being hospitalised with what looked to be similar neurological symptoms - but diagnostic testing later showed that these infections were caused by the Chikungunya virus. The debilitating illness, which can cause fever and long-lasting joint pain, may also result in impaired consciousness and cognitive issues in some children. This year has seen an unprecedented surge of Chikungunya infections reported worldwide - including hundreds of cases being detected in Kenya. Nearly a decade on from the studies in Kilifi, a global research team are now working together to give doctors and scientists a better sense of just how widespread Chikungunya really is in the region. "The study has potential to yield significant public health benefits” says Professor George Warimwe (Nuffield Department of Medicine), including helping know who is most affected and where. These insights can help design future vaccine trials and guide decisions on how Chikungunya vaccine doses should be distributed. The $10.3 million research programme, known as Accelerating CHIkungunya burden Estimation to inform Vaccine Evaluation (ACHIEVE), is supported by CEPI. Discover more in our blog linked in the Comments.

LinkedIn (www.linkedin.com)

14/12 "'We are dying': Cuba sinks into a health crisis amid medicine shortages and misdiagnosis ' International ' EL PAÍS English"

Hospitals are overwhelmed and fatalities are soaring. The island is suffering from combined viruses that include dengue, chikungunya, Oropouche and other respiratory diseases

‘We are dying’: Cuba sinks into a health crisis amid medicine shortages and misdiagnosis

Hospitals are overwhelmed and fatalities are soaring. The island is suffering from combined viruses that include dengue, chikungunya, Oropouche and other respiratory diseases

EL PAÍS English (english.elpais.com)

10/12 "Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ "

Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ® - Valneva

IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after twelve months in both dose groups, although more robust with the full dose Twelve-month data continues to support full dose selection for a future Phase 3 trial Saint-Herblain (France), December […]

Valneva (valneva.com)

11/12 https://www.biospace.com/press-releases/valneva-reports-positive-final-phase-2-antibody-persistence-and-safety-results-in-children-for-its-chikungunya-vaccine-ixchiq

12/12 https://pharmavanguard.com/news/valneva-chikungunya-vaccine-positive-in-kids-phase-2-trial/

12/12 "Scientists launch largest-ever study tracking chikungunya burden in East Africa"

A team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa.

Scientists launch largest-ever study tracking chikungunya burden in East Africa

Led by the University of Oxford, researchers are set to investigate the number of children and adults affected by chikungunya in Kenya and Tanzania.

(cepi.net)

9/12 "Chikungunya case numbers surpass 400 in Italy ' Travel Doctor-TMVC" (Australien)

Jeg har ikke undersøgt, hvilke vacciner er godkendt i AUS...

403 Forbidden

(www.traveldoctor.com.au)

Afrika

Droner

"Africa CDC and Zipline Partner to Advance Health System Responsiveness and Epidemic Preparedness Across Africa - Africa CDC"

Africa CDC and Zipline Partner to Advance Health System Responsiveness and Epidemic Preparedness Across Africa – Africa CDC

Together, they will expand access, improve emergency preparedness, strengthen data systems, and enhance epidemic early warning and response capabilities that work even at the last mile Washington / Addis Ababa, 11 December 2025 — The Africa Centres for Disease Control and Prevention (Africa CDC) and Zipline International, Inc. have signed a Memorandum of Understanding (MoU) to improve health outcomes and expand […]

Africa CDC (africacdc.org)

Torsdags Briefing: 11/12

Der hentydes til, at Mpox PHECS bliver aflyst primo denne uge.

https://www.youtube.com/watch?v=_F_5dh_YSE0

Mpox

9/12 Gavi "A new mpox variant has been identified in the UK. Should we be worried?
The new strain combines both currently recognised strains of the virus - clade I and clade II. Scientists are watching closely."

https://www.gavi.org/vaccineswork/new-mpox-variant-has-been-identified-uk-should-we-be-worried"

5/12 WHO "Disease Outbreak News - Broader transmission of mpox due to clade Ib MPXV - Global situation"

The purpose of this report is to raise awareness about the local transmission of clade Ib monkeypox virus (MPXV) among men who have sex with men (MSM) in countries previously unaffected or to date reporting only cases linked to travel. This report summarizes recent epidemiological developments, response activities, and the associated global public health risk.

Broader transmission of mpox due to clade Ib MPXV – Global situation

The purpose of this report is to raise awareness about the local transmission of clade Ib monkeypox virus (MPXV) among men who have sex with men (MSM) in countries previously unaffected or to date reporting only cases linked to travel. This report summarizes recent epidemiological developments, response activities, and the associated global public health risk. The second declaration of a public health emergency of international concern (PHEIC) for mpox was lifted on 5 September 2025. As both MPXV clades I and II and their subclades continue to circulate globally, leading to substantial outbreaks in African countries, WHO continues to advise emergency preparedness and response activities. Multiple modes of transmission underlie ongoing virus circulation, with sexual contact remaining the primary amplifier of transmission in most settings. Since 5 September 2025, several countries across four of six WHO regions have confirmed clade Ib MPXV infection in individuals with no recent travel reported (WHO African Region, Region of the Americas, the European Region and the Western Pacific Region), most of which are being detected among men who have sex with men, suggesting local transmission, particularly given that infections often manifest with few or no symptoms (paucisymptomatic or asymptomatic cases) leading to undetected onward transmission. Overall, the surveillance data in most countries is sufficient to detect and respond effectively to mpox outbreaks. However, thorough epidemiological investigation, contact tracing and implementation of public health interventions to control spread remain challenging. Mpox is known to resolve on its own over two to four weeks in most cases. However, timely access to quality healthcare is essential to identify, prevent and manage secondary bacterial infections and other complications. Individuals living with immune suppressive conditions remain at high risk of more severe mpox disease and death, most notably people living with undetected and/or untreated, uncontrolled human immunodeficiency virus (HIV) infection. Men who have sex with men with new and/or multiple partners remain at increased risk of clade Ib and also IIb MPXV infection. WHO assesses the public health risk posed by clade Ib MPXV to men who have sex with men as moderate and the risk to the general population as low in most countries.

(www.who.int)

5/12 WHO "Global Mpox Trends"

https://worldhealthorg.shinyapps.io/mpx_global/#sec-global

8/12 WHO Multi-country outbreak of mpox, External situation report #60 - 8 December 2025

Multi-country outbreak of mpox, External situation report #60 - 8 December 2025

Publications of the World Health Organization

(www.who.int)

Det er blevet sværere at følge med i, hvem der donerer vacciner... jf. bl.a.:

Side 9

"Other countries that recently reported mpox are developing national mpox vaccination plans and are encouraged to consider dose-sparing options of the MVA-BN vaccine."

Og

"Additional doses have been donated and procured; funding is still needed to secure additional vaccine supply from manufacturers. The AAM partners continue to work together to support access to mpox vaccines and secure operational funds for implementation of national mpox vaccination plans."

Chikungunya

5/12 CDC - Travel alert

Areas at Risk for Chikungunya

Countries with evidence of chikungunya transmission. Some U.S. travelers may consider vaccination.

Chikungunya Virus (www.cdc.gov)

8/12 "CDC warns Americans traveling to 4 countries over outbreak of untreatable mosquito disease"

CDC warns Americans traveling to 4 countries over outbreak of untreatable mosquito disease

CDC issues travel advisories for Cuba, Bangladesh, Sri Lanka and China due to serious chikungunya outbreak affecting hundreds of thousands of people globally.

Fox News (www.foxnews.com)

5/12 "Chikungunya in children" Sri Lanka Journal of Child Health - A4-ark : Kan downloades her:

https://sljch.sljol.info/articles/10.4038/sljch.v54i4.11693?

"During the chikungunya outbreak in La Réunion, 25% of
children developed neurological symptoms and in India,
14% of all children presenting with suspected CNS
infection had chikungunya. Among these, 40-50% had
severe manifestations, including status epilepticus,
complex seizures and encephalitis.

Sundhed.dk :

Danske sundhedsplatforme er ikke opdateret, hvad angår Chikungunya.

Ville have troet, at BN ville sikre kontakt til fx Sundhed.dk, danske vaccinationscentre m.fl. for at sikre retvisende opdatering om Chikungunya hvor relevant.

Fx Artiklen 'Chikungunya-feber" i Lægehåndbogen (fagperson) på sundhed.dk trænger til en gennemgribende opdatering. Bl.a. nævnes, at der kun findes 1 vaccine, nemlig Valneva's IXCHIQ. Ud over vacciner, bør emnerne
Graviditet/perinatal smitte
Vertikal smitte/teratogenicitet
Epidemiologi (Forekomst)
Komplikationer hos nyfødte
også opdates.

Chikungunya-feber - Lægehåndbogen på sundhed.dk

(www.sundhed.dk)

Patienthåndbogen er endnu mere håbløs. Her nævnes de seneste udbrud fra 2005 og 2007. Vacciner nævnes slet ikke og der er tilsyneladende ingen fare: "Chikungunyafeber går over af sig selv. Der er som regel kun behov for lindrende behandling i form af smertestillende medicin."

Chikungunya-feber - Patienthåndbogen på sundhed.dk

(www.sundhed.dk)

Afrika

Torsdags Briefing:

Ifølge briefingen har Africa CDC fortsat diskussioner med Bavarian Nordic om hvordan Tech Transfer kan finde sted fra Bavarian Nordic til Syd Afrika "funding is missing to support 3-4 mio. doses needed to support local manufacturing." ca. 41:00 - lyt med fra ca. 37:30 (Q/A) vedr. Vaccine Manufacturing in Afrika.

(Mon den mpox-stockpile Gavi vil etablere i sommeren 2025 kunne bidrage til etablering af local manufacturing?)

Der nævnes endvidere, at et møde finder sted i denne uge, hvor der skal tages stilling til at anbefale om PHECS skal fortsætte eller ophæves.

Mpox fylder mindre og mindre i briefingen - nu hvor mpox snart forventes at overgå til "primary healthcare" i de enkelte lande. Det fortælles, at tallene for mpox falder fortsat i Afrika. Mit indtryk er: når man ikke tester, finder man heller ikke noget.

Kolera er meget mere dødelig og fylder derfor forståeligt nok mere og mere i briefingen. Africa CDC anvender samme skabelon, der er bygget op omkring håndtering af Mpox, til at håntere nye udbrud, herunder kolera.

https://www.youtube.com/watch?v=3xYcM06BhPc&t=3618s

23/11 G20 - Proffessor "Jeffrey Sachs ROASTS Trump for Skipping the G20 Summit in South Africa!"

Historielektion om USA, Europa, USSR & Kina.

28 minutter godt givet ud.

Bavarian Nordic

4/12 Science Business "Beyond the battlefield: Rethinking defence to integrate biological preparedness"

• Roundtable meeting. Mon også BN deltager / er inviteret?

Se guestliste samt foreløbig agenda.

Just a moment...

(sciencebusiness.net)

Mpox

19/11 WHO - European Region - "What is the situation with Mpox in the WHO European Region?"

What is the situation with Mpox in the WHO European Region? Local transmission of clade I mpox marks a new phase for the strain in the European Region. Since the 2022 global mpox outbreak began,… | WHO Regional Office for Europe

What is the situation with Mpox in the WHO European Region? Local transmission of clade I mpox marks a new phase for the strain in the European Region. Since the 2022 global mpox outbreak began, the WHO European Region has recorded more than 31,000 mpox cases. 2025 has seen a steady pattern of 200–300 new cases every month, mostly associated with clade IIb. However, clade I, historically confined to parts of Central Africa, is now being detected more frequently in Europe. To date, the Region has confirmed 72 clade Ib cases, alongside a small number of clade Ia cases and a few still under classification. Initially detected outside Africa in 2024 through cases linked to travel, in 2025, several European countries have now reported clade Ib infections in individuals with no travel history at all. This shift marks the first clear evidence of local circulation of this strain within the Region. Some of these infections have occurred among men who have sex with men (MSM), suggesting that clade Ib has begun to establish itself within the same sexual networks associated with the 2022–23 clade IIb outbreak. The virus requires very close physical contact to spread. Most people recover within a few weeks without medical treatment. Although there still remains uncertainty around the disease severity, infection with clade I can be more severe than clade II in young children, pregnant women, and those who are immunocompromised. WHO currently assesses the overall public-health risk as moderate for MSM and low for the wider population outside historically endemic regions. Sustained surveillance, rapid identification and isolation of cases, timely sharing of data, and community-centred communication on risk reduction behaviours—free from stigma—remain the backbone of mpox control. Vaccination continues to be an important tool, especially for those at higher risk. As we’ve seen repeatedly since 2022, supportive care, and non-discriminatory public health responses make all the difference. The emergence and local spread of clade Ib is a reminder that mpox continues to evolve, and our vigilance must evolve with it.

LinkedIn (www.linkedin.com)

19/11 "The Clade I MPOX Variant is Here. Are We Sleepwalking Again?"

The Clade I MPOX Variant is Here. Are We Sleepwalking Again?

We're patting ourselves on the back for MPOX victories in places like Australia while ignoring the terrifying reality: a deadlier Clade I variant is spreading in Los Angeles. This isn't a paradox; it's a predictable failure. This article dissects the stark contrast between proactive, community-based MPOX control strategy and the bureaucratic inertia that invites disaster. We are sleepwalking into another crisis, and it's time to wake up.

Made-in-China.com (insights.made-in-china.com)

18/11 "Mpox cases remain elevated in New York City as officials renew vaccination push"

Mpox cases remain elevated in New York City as officials renew vaccination push

Mpox continues to circulate at elevated levels in New York City, with 63 cases reported in October — surpassing September’s yearly high of 61 — and several

Gay City News (gaycitynews.com)

7/11 UK Health Security Agency and NaTHNaC "Chikungunya virus disease- Global situation report 2025"

(travelhealthpro.org.uk)

4/11 Springer Nature Link "Re-emergence and clinical management of monkeypox: insights into viral biology, therapeutics, and vaccination" + " Vaccination remains the most effective preventive measure. Currently approved vaccines include ACAM2000, LC16 KMB, and JYNNEOS (MVA-BN), with JYNNEOS preferred due to its safety profile, especially for immunocompromised individuals and pregnant women."

https://link.springer.com/article/10.1007/s11033-025-11215-6

Chikungunya

Så er Frankrig og Tyskland søreme også kommet på Bavarian Nordics hjemmeside for Chikungunya... ENDELIG.... Vimkunya blev rullet ud i Frankrig og Tyskland før skandinavien. Men det måtte omverdenen / vi aktionærer tilsyneladende ikke vide før nu.... / ved Q3.

Noget primitiv indgangside på pc... Ser mere prof ud på mobil.

Chikungunya Disease - chikungunya

Select your country ✕ Select your country Choose a region to continue to the localized site. 🇩🇪 Germany 🇩🇰 Denmark 🇸🇪 Sweden 🇫🇮 Finland 🇳🇴 Norway 🇬🇧 Great Britain 🇫🇷 France 🇺🇸 United States 🇦🇹 Austria 🇨🇭 Switzerland (FR) 🇨🇭 Switzerland (DE)

chikungunya (chikungunya.com)

25/11 "More than 100 people in intensive care due to chikungunya and dengue in Cuba, the majority of whom are children"

More than 100 people in intensive care for chikungunya and dengue in Cuba, the majority are children

Cuba is facing a serious health crisis due to chikungunya and dengue, with over 100 people in intensive care, the majority of whom are children. The lack of resources and vector control is worsening the situation as infections continue to rise.

CiberCuba (en.cibercuba.com)

24/11 "Public Health strengthens epidemiological surveillance in the face of chikungunya circulation in Cuba"

De Último Minuto

(deultimominuto.net)

19/11 NIH "Chikungunya Vaccine License Receives LES Deal of Distinction Award"
(Denne nyhed måtte Bavarian Nordic gerne gøre lidt larm over)

Chikungunya Vaccine License Receives LES Deal of Distinction Award | Technology Transfer

(www.techtransfer.nih.gov)

19/11 American Society for Microbiology "Climate, Vectors and Virus Keep Chikungunya a Global Focus"
Bemærk udgivelsesdato - artiklen skriver fejlagtigt at der er 2 vacciner i USA.

Climate, Vectors and Virus Keep Chikungunya a Global Focus | ASM.org

Chikungunya virus activity surged globally in 2025. Understanding transmission dynamics and factors driving outbreaks is crucial for prevention and control.

ASM.org (asm.org)

19/11 Canada Tvnews "PHAC clarifies travel advisory issued over chikungunya"

https://www.ctvnews.ca/canada/article/phac-clarifies-travel-advisory-issued-over-chikungunya/

Afrika

19/11 TopAfricaNews: "Kigali facility revs up Africa's vaccine self-reliance"

"The Kigali investment signals a broader structural shift in how Africa's health sector is being industrialised, through blended financing, policy alignment, and local entrepreneurship."

Kigali facility revs up Africa’s vaccine self-reliance | TOP AFRICA NEWS

Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ecosystem, bridging the gap between ambition and large-scale production. Bonface Orucho, bird story agency A new European financial backing of BioNTech’s mRNA vaccine facility in Kigali marks a defining step in Africa’s long-term pursuit of health and industrial

TOP AFRICA NEWS | Amplifying Development Impact (www.topafricanews.com)

20/11 Africa CDC Torsdag Press Briefing

De første 10 minutter er især værd at lytte til.

Mere om systemskiftet I Africa: "The Africa's Health Security and Soveignity agenda. A new way forward." The 5 pillars.

Godt indblik i hvad der sker i Africa. USA's udtræden fra "global aid" har tvunget Africa til at redefinere sig selv. Africa Leads! The new era - the new way forward.
Pandemic Preparedness Funding gennemgås blandt meget andet.

https://www.youtube.com/watch?v=tsYMTwOtTUY

Organisationer

19/11 WHO "Public notice and comments on the Guideline Development Group for WHO Guideline on testing and testing strategies for mpox"

Public notice and comments on the Guideline Development Group for WHO Guideline on testing and testing strategies for mpox

Deadline for public comments: 03 December 2025BackgroundMpox is a viral disease caused by the mpox virus, a member of the Poxviridae family - same family of viruses as smallpox. While it was discovered in 1958 in a captive monkey during a vaccine research in Denmark, it was first identified in humans in 1970 in the Democratic Republic of the Congo. In recent years, it has caused various outbreaks that spread outside Africa and warranted the WHO Director-General to declare two Public Health Emergencies of International Concern (PHEICs): one in 2022 during the global multi-country outbreak, and another in 2024 following a resurgence of cases in Central Africa with cross-border spread. These declarations underscore the growing international health threat posed by mpox and the need for sustained surveillance, rapid response, and equitable access to diagnostics, vaccines, and treatments. Laboratory testing is the basis for an efficient surveillance system, and therefore, the WHO is transitioning its interim guidance on diagnostic testing and testing strategies for mpox into a formal guideline.The guideline aims to provide evidence-based recommendations for testing and testing strategies for mpox, with the overarching goal of reducing transmission, minimizing morbidity and mortality, and strengthening preparedness and response capacities at national and global levels.Comments and perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s Conflicts of Interest assessment policy to strengthen public trust and transparency in connection with WHO meetings involving the provision of technical/normative advice. Comments and perceptions will be carefully reviewed and treated confidentially. The comments will not be published and will be kept on record. WHO reserves the right to discuss information received through this process with the relevant expert, with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies. The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization, nor does it create a binding relationship between the expert and WHO. The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interest, will be reported publicly in accordance with WHO practice.Comments should be provided by email, and the receipt of these will be acknowledged through a generic email notification to the sender.Please send your comment to mpox@who.int  with the subject “Public notice and comments on the WHO Guideline Development Group for testing for mpox ” with indication of the name, nature, and contact details of the sender.The deadline for public comments is  03 December 2025Guideline Development Group (GDG) Members – Testing Guidelines for MpoxBiographies of the currently proposed members:Download 

(www.who.int)

UNAIDS.ORG - The Global Council on Inequality, AIDS and Pandemics "Breaking the inequality-pandemic cycle - Building true health security in a global age"
Findings and recommendations of the Global Council
Executive Summary side 5

https://www.unaids.org/sites/default/files/2025-11/2025_global-council-inequality-report_en.pdf

18/11 CEPI - "Towards Regionalised Vaccine Manufacturing" First Status Report

CEPI (@CEPIvaccines) on X

Strengthening regionalised vaccine manufacturing is central to CEPI’s mission to ensure equitable access to vaccines, and we will continue to work with partners like RVMC to achieve this ambition. Read full report: https://t.co/8HYK9MTjQn

X (formerly Twitter) (x.com)

& https://bit.ly/3JGVtCJ

18/11 The Seattle Times "MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts"

(www.seattletimes.com)

23/11 G20 - "Finland President Stubb Says West Is ‘Stuck In 1945’, Calls For Power Shift Recognising India’s Rise"

Finland’s President Alexander Stubb delivered a blunt and unprecedented admission: the Western-dominated global order built in 1945 is no longer fair, functional, or reflective of today’s world.

Så kort kan det siges. 3 minutter !

https://www.youtube.com/watch?v=C4vbFMTNPas

23/11 G20 - Proffessor "Jeffrey Sachs ROASTS Trump for Skipping the G20 Summit in South Africa!"

Historielektion om USA, Europa, USSR & Kina.

28 minutter godt givet ud.

Andet

25/11 "Piercing the limits ' Patenting in the age of needle-free vaccines"

https://www.spruson.com/piercing-the-limits-patenting-in-the-age-of-needle-free-vaccines/

14/11 - PubMed / Journal og Global Health

"Strengthening the mpox response: how do we balance pragmatism and equity in resource-constrained settings?"

Checking your browser - reCAPTCHA

(pmc.ncbi.nlm.nih.gov)

7/11 The Lancet

"Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium"

ScienceDirect

(www.sciencedirect.com)

Chikungunya

17/11 ECDC - "Chikungunya virus disease worldwide overview"

Chikungunya virus disease worldwide overview

Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).

European Centre for Disease Prevention and Control (www.ecdc.europa.eu)

17/11 ECDC - "12-month Chikungunya virus disease case notification rate per 100 000 population, November 2024-October 2025"

12-month Chikungunya virus disease case notification rate per 100 000 population, November 2024-October 2025

In 2025, there have been 458 840 CHIKVD cases and 146 associated deaths reported worldwide. Cases have increased when compared to the same period in 2024.

European Centre for Disease Prevention and Control (www.ecdc.europa.eu)

17/11 Newsweek - "Pan American Health Organization: Insect-Borne Diseases Are Impacting US. Here’s What To Do"

Pan American Health Organization: Insect-Borne Diseases Are Impacting US. Here’s What To Do | Opinion

The appearance of chikungunya in New York should be cause for concern but not panic. 

Newsweek (www.newsweek.com)

15/11 MotherJones : "This Invasive Disease Carrier Is Showing Up in Places It Really Shouldn't Be" (Colorado )

This invasive disease carrier is showing up in places it really shouldn't be

A mosquito that can spread chikungunya, dengue, and Zika is now thriving in western Colorado and elsewhere.

Mother Jones (www.motherjones.com)

12/11 Kenya: "Officials issue warning as dangerous virus spreads rapidly: 'We noticed increasing numbers of patients'
"Ten years ago, this disease was not there.""

Officials issue warning as dangerous virus spreads rapidly: 'We noticed increasing numbers of patients'

The chikungunya virus is rapidly spreading in Mombasa County, Kenya, and has infected almost half a million people worldwide this year.

The Cool Down (www.thecooldown.com)

11/11 Frontiers - "Chikungunya fever: pathogenesis and mechanisms underlying pain symptoms"

Frontiers | Chikungunya fever: pathogenesis and mechanisms underlying pain symptoms

Chikungunya fever (CHIKF), caused by the Chikungunya virus (CHIKV) and transmitted by Aedes mosquitoes, has rapidly evolved from localized outbreaks to a sig...

Frontiers (www.frontiersin.org)

12/11 VaccinesWork - "A mosquito that can carry dengue has landed in the Rockies"

A mosquito that can carry dengue has landed in the Rockies

It was thought that Aedes aegypti could not survive in the Mountain West. But now, a population is thriving in Colorado.

(www.gavi.org)

8/11 "Chikungunya Virus Spreading Nationwide in Cuba"

Just a moment...

(havanatimes.org)

Afrika

17/11 The lancet

"Africa's Health Security and Sovereignty agenda: a new way forward" = AHSS

By D.G. Dr. Jean Kaseya

Nem og gratis engangs-adgang til artiklen.

Just a moment...

(www.thelancet.com)

8/11 The Lancet

"Africa leads, multilateral health organisations support"

Just a moment...

(www.thelancet.com)

13/11 Africa CDC Press Briefing

(Første gang i lang tid med D.G. Dr. Jean Kaseya)

https://www.youtube.com/watch?v=Lsb0fLpgRCs

13:30 Requesting more mpox vaccines

18:40 5 minuter med Health Minister Austin Dembyra Sierra Leone: How the Mpox-outbreak in Sierra Leone was succesfully managed. The model for managing future outbreaks in Africa. Very Science driven. (mere under Q/A)

fra ca. 23:00 Q/A
Q vedrørende mpox
25:00 - 31:00 hvordan Sierra Leone skiftede strategi
34:00 - 39:00 Is the Sierra Leone currently negotiating with the USA a bilateral agreement with the America first. (interessant)
40:00 Community based health insurance programme
42:30 - 47:00 "If you don't have a plan - then other people will have a plan for you!" The "4 A's".
"The financial headwinds we are facing creates a real opportunity for us get things right and do things better"
47:00 - 50:00 Mpox - the future in Sierra Leone - a new national public health agency in the country. Primary Health Care will discover and take care of future outbreaks.
56:00 - Health Sovereignty in a country- what does that mean and how to achieve it!
Countries are taking leadership now.
Not close-ended project that we are used to.
Not decease-focused intervention, that we are used to.
59:00 Major concerns : mpox, lasso fever, uderfunded health systems, health climate: dengue, chicungunya mv.

8/11 "Dr Jean Kaseya (Director General, Africa CDC)
reflects on the AU-EU Health Partnership"

Bl.a. Local manufacturing of vaccines.

https://www.youtube.com/watch?v=s0N9gByXJxY (10 min.)

11/11 - Health Business

"Africa Must Deepen Regulatory Cooperation to Achieve Health Sovereignty, Says PPB Chair Dr John Munyu"

Africa Must Deepen Regulatory Cooperation to Achieve Health Sovereignty, Says PPB Chair Dr John Munyu

Pharmacy and Poisons Board (PPB) Chairperson Dr John Munyu, MBS, has called on African countries to accelerate regulatory harmonisation and

Health Business (healthbusiness.co.ke)

Organisationer

WHO - "Public advice on mpox vaccination"

(har ikke set denne side før...)

Public advice on mpox vaccination

(www.who.int)

3/11 WHO - EU

"One Health. One Planet. Our Responsibility.
Time for action: a joint statement of the EU Cross-agency One Health Task Force and the European and Central Asia Quadripartite on One Health"

One Health. One Planet. Our Responsibility.

As wildfires, heatwaves, floods and other interconnected crises intensify in 2025, recognizing the link between human, animal and environmental health – and acting across sectors – is essential.

(www.who.int)

"The Durban Promise marked the birth of Africa's Health Sovereignty Movement, a commitment to manufacture its own vaccines, finance resilient systems, transform primary health care, prepare for pandemics, empower its people, and own its data. This was not just a conference outcome - it was a continental call to action, turning crisis into opportunity and aspiration into action."

Læs mere her:

(financingalliance.org)

"October delivered a significant boost to global epidemic and pandemic preparedness as Germany strengthened its backing for CEPI, reaffirming its global health leadership with a new EUR 100 million five-year pledge."

Læs mere her:

Germany fortifies the global pandemic shield with new pledge to CEPI

October delivered a significant boost to global epidemic and pandemic preparedness as Germany strengthened its backing for CEPI, reaffirming its global health leadership with a new EUR 100 million five-year pledge. As one of CEPI’s longest-standing and largest funders, Germany will continue to help

(www.linkedin.com)

Interview with Martin Seychell, Deputy Director-General, INTPA

Why is investing in regional and local manufacturing capacity essential to strengthening health security, and what is the EU doing to support it?

HERA - Interview with Martin Seychell, Deputy Director-General, INTPA

(ec.europa.eu)

Referat

I interviewet fremhæver Martin Seychell, Deputy Director-General i DG INTERNATIONAL PARTNERSHIPS (INTPA), at global sundhed ikke kun handler om akutte kriser, men også om at skabe bæredygtig velfærd og stabilitet i samfundet.

Han peger på, at selvom økonomisk vækst finder sted i mange lande, betyder vækst alene ikke meget, hvis den ikke omsættes til bedre sundhed og livskvalitet.

Et centralt fokus er at investere i regional og lokal fremstilling af medicinske produkter - vacciner, medicin, diagnostik osv. - fordi erfaringen fra COVID-19 viste, at store dele af verden var ekstremt afhængige af import, fx underforsyning i sub-Sahara Afrika og Latinamerika.

Ved at styrke produktionen regionalt reduceres sårbarheden over for afbrudte forsyningskæder, eksportstop og manglende adgang under kriser.

Han beskriver, at EU's tiltag retter sig mod både at hjælpe partnerlande med at udvikle egne kapaciteter og at samarbejde globalt for at sikre mere retfærdig adgang til medicinske modforanstaltninger.

Endvidere fastslår han, at selvom globale sundhedstrusler (pandemier, smitsomme sygdomme) er akut vigtige, må indsatsen også omfatte det, der foregår "imellem kriserne" - opbygning af robuste sundhedssystemer og forebyggelse.

*INTPA

INTPA samarbejder tæt med bl.a. HERA, Udenrigstjenesten (EEAS) og WHO for at styrke global modstandskraft, bl.a. gennem støtte til regional og lokal produktion af sundhedsprodukter i Afrika, Latinamerika og Asien.

INTPA står for Generaldirektoratet for Internationale Partnerskaber (Directorate-General for International Partnerships) og er en del af Europa-Kommissionen.

INTPA har ansvaret for EU's politik for internationalt samarbejde og udvikling. Målet er at bekæmpe fattigdom, fremme bæredygtig udvikling og støtte global stabilitet.

Arbejdet omfatter bl.a.:

• global sundhed og pandemiforberedelse
• klima og miljø
• digital omstilling
• uddannelse og ligestilling
• fred, god regeringsførelse og menneskerettigheder

INTPA samarbejder tæt med bl.a. HERA, Udenrigstjenesten (EEAS) og WHO for at styrke global modstandskraft, bl.a. gennem støtte til regional og lokal produktion af sundhedsprodukter i Afrika, Latinamerika og Asien.